SCHEMBL4757147

SCHEMBL4757147

COC(=O)c1nc(NC(=O)c2cc(Cl)c(O)cc2F)sc1S(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.40
NPSR1 Q6W5P4 3/20 0.40
RXFP1 Q9HBX9 2/20 0.40
GAA P10253 1/20 0.40
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
RAB9A P51151 6/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
HSD17B10 Q99714 3/20 0.38
ALDH1A1 P00352 3/20 0.38
SCN9A Q15858 2/20 0.38
TP53 P04637 2/20 0.38
HPGD P15428 1/20 0.38
NPC1 O15118 5/20 0.37
POLA1 P09884 1/20 0.36
GRM4 Q14833 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
GHSR Q92847 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4756888 0.82 HSD17B1 (0.40) KDM4ENPSR1RXFP1GAAHSD17B1
SCHEMBL4757274 0.76 NPC1 (0.39) KDM4ERXFP1GAAHSD17B1HSD17B2
SCHEMBL8349593 0.71 GAA (0.46) KDM4EGAAMEN1KMT2AHSD17B10
SCHEMBL4756535 0.66 RAB9A (0.57) KDM4ENPSR1RXFP1GAARAB9A
SCHEMBL9617792 0.66 CA12 (0.44) KDM4EGAARAB9AMEN1KMT2A
SCHEMBL4757308 0.65 KDM4E (0.41) KDM4ERXFP1GAARAB9AMEN1
SCHEMBL4757204 0.65 FFAR2 (0.44) KDM4ERXFP1RAB9ASCN9ANPC1
SCHEMBL10114630 0.64 SCN9A (0.41) SCN9A
SCHEMBL10114545 0.64 SCN9A (0.41) NPSR1RAB9AMEN1KMT2AHSD17B10
SCHEMBL4756579 0.63 HSPD1 (0.46) KDM4ENPSR1RXFP1GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDM4E 2428/4885NPSR1 4396/4885RXFP1 4741/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDM4E 2428/4885NPSR1 4396/4885RXFP1 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.